Long term efficacy of Bosentan in the therapy of systemic sclerosis associated pulmonary arterial hypertension

被引：0
|
作者：
Iannone, F [1 ]
Riccardi, MT [1 ]
Chialà, A [1 ]
Anelli, MG [1 ]
Conforti, ML [1 ]
Guiducci, S [1 ]
Albanese, L [1 ]
Cerinic, MM [1 ]
Lapadula, G [1 ]
机构：
[1] Univ Bari, Rheumatol Unit, Bari, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [1] Long term treatment with bosentan for pulmonary arterial hypertension related to systemic sclerosis
    Cozzi, F
    Montisci, R
    Marotta, H
    Bobbo, F
    Favaro, M
    Tiso, F
    Ciprian, L
    Iliceto, S
    Todesco, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 297 - 297
  • [2] LONG-TERM OUTCOME WITH FIRST-LINE BOSENTAN THERAPY IN SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Launay, D.
    Sitbon, O.
    Le Pavec, J.
    Savale, L.
    Tcherakian, C.
    Yaici, A.
    Achouh, L.
    Parent, F.
    Jais, X.
    Simonneau, G.
    Humbert, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S159 - S159
  • [3] Long-term outcome with first-line bosentan therapy in systemic sclerosis-associated pulmonary arterial hypertension
    Launay, David
    Sitbon, Olivier
    Jais, Xavier
    Yaici, Azzedine
    Le Pavec, Jerome
    Tcherakian, Colas
    Humbert, Marc
    Simonneau, Gerald
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S819 - S819
  • [4] Therapy for pulmonary arterial hypertension associated with systemic sclerosis
    Mathai, Stephen C.
    Hassoun, Paul M.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (06) : 642 - 648
  • [5] Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis
    Murdaca, Giuseppe
    Lantieri, Francesca
    Puppo, Francesco
    Bezante, Gian Paolo
    Balbi, Manrico
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 : 85 - 89
  • [6] Bosentan treatment in pulmonary arterial hypertension secondary to systemic sclerosis
    Piludu, G.
    Nalli, E.
    Amoresano, D.
    Farci, M.
    Muttini, T.
    D'Aietti, I
    Mura, N.
    Loddo, M.
    Giacco, G.
    [J]. ALLERGY, 2008, 63 : 353 - 353
  • [7] Experience with bosentan in pulmonary arterial hypertension secondary to systemic sclerosis
    Caroline Barranco
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 (4): : 181 - 181
  • [8] Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
    Hislop, A. A.
    Moledina, S.
    Foster, H.
    Schulze-Neick, I.
    Haworth, S. G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 70 - 77
  • [9] Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers
    Jain, Manu
    Varga, John
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (11) : 1487 - 1501
  • [10] Bosentan: A review of its use in pulmonary arterial hypertension and systemic sclerosis
    Oldfield V.
    Lyseng-Williamson K.A.
    [J]. American Journal of Cardiovascular Drugs, 2006, 6 (3) : 189 - 208
12345